Eysteinsson Thor

Retinal oximetry: Metabolic imaging for diseases of the retina and brain.

It senses hypoxia in cardiac and pulmonary diseases. Oximetry biomarkers have been discovered in Alzheimer's disease and multiple sclerosis and oxygen levels in the retina correspond well with brain.

Retinal Oximetry Discovers Novel Biomarkers in Retinal and Brain Diseases.

Retinal oximetry is a novel, noninvasive technology that opens the field of metabolic imaging of the retina. Biomarkers in metabolic, ischemic, and atrophic diseases of the retina and central nervous system have been discovered.